E-LIB Suche - Ergebnisse für: Magaz, S

1

PDB28 VALIDATION OF ORAL ANTIDIABETIC DRUGS PRESCRIPTIONS: ..:

Gutierrez, L ; Magaz, S ; Badia, X
Value in Health. 7 (2004) 6 - p. 743-744 , 2004

Link: https://doi.org/10.1016/..

2

COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VERSUS IN..:

Oppenheimer, F ; Rubio, M ; Magaz, S.
Transplantation. 78 (2004) - p. 486 , 2004

Link: https://doi.org/10.1097/..

3

PAR28 ASSESSING INTANGIBLES IN BIOLOGIC THERAPIES FOR RHEUM..:

Badia, X ; Serrano, D ; Magaz, S
Value in Health. 7 (2004) 6 - p. 669 , 2004

Link: https://doi.org/10.1016/..

4

PAR9 A COST MINIMISATION ANALYSE FOR STUDYING THE EFFICIENC..:

Badia, X ; Serrano, D ; Magaz, S
Value in Health. 7 (2004) 6 - p. 663 , 2004

Link: https://doi.org/10.1016/..

5

PIN7 COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VS. ..:

Rubio, M ; Oppenheimer, F ; Magaz, S.
Value in Health. 7 (2004) 6 - p. 760 , 2004

Link: https://doi.org/10.1016/..

6

PCV62 CLINICAL AND ECONOMIC OUTCOMES OF FONDAPARINUX VS. EN..:

Slof, J ; Magaz, S ; Badia, X
Value in Health. 6 (2003) 6 - p. 667 , 2003

Link: https://doi.org/10.1016/..

7

PNM5 MANAGEMENT COSTS OF CHEST AND CNSRELATED ADVERSE EVENT..:

Slof, J ; Magaz, S ; Badia, X..
Value in Health. 6 (2003) 6 - p. 763 , 2003

Link: https://doi.org/10.1016/..

8

PIN16 COST-EFFECTIVENESS ANALYSIS OF FUZEON ADDED TO OPTIMA..:

Serrano, D ; Magaz, S ; Badia, X..
Value in Health. 6 (2003) 6 - p. 751 , 2003

Link: https://doi.org/10.1016/..

9

PAE14 COST-EFFECTIVENESS ANALYSIS OF PMMA, SILICONE, AND AC..:

Smith, AF ; Lafuma, A ; Berto, P...
Value in Health. 6 (2003) 6 - p. 640-641 , 2003

Link: https://doi.org/10.1016/..

10

PIN31 COST-EFFECTIVENESS ANALYSIS OF ONCEDAILY MODIFIED REL..:

Rubio, M ; Magaz, S ; Badia, X
Value in Health. 6 (2003) 6 - p. 756-757 , 2003

Link: https://doi.org/10.1016/..

11

RX1 PRESCRIPTION DRUG INFORMATION: A SURVEY OF THE GENERAL ..:

Badia, X ; Magaz, S ; Gutierrez, L
Value in Health. 6 (2003) 6 - p. 631 , 2003

Link: https://doi.org/10.1016/..

12

PCV64 COST-EFFECTIVENESS ANALYSIS OF CORONARY REVASCULARISA..:

Magaz, S ; Badia, X ; Annemans, L.
Value in Health. 6 (2003) 6 - p. 668 , 2003

Link: https://doi.org/10.1016/..

13

PUK6 COST-MINIMIZATION ANALYSIS OF TENSIONFREE VAGINAL TAPE..:

Lahoz, R ; Magaz, S ; Badia, X...
Value in Health. 6 (2003) 6 - p. 701 , 2003

Link: https://doi.org/10.1016/..

14

PCN9 COST-EFFICACY OF ZOLEDRONIC 4MG ACID VS. PAMIDRONATE 9..:

Badia, X ; Slof, EJ ; Magaz, S...
Value in Health. 5 (2002) 6 - p. 539-540 , 2002

Link: https://doi.org/10.1016/..

15

PNP6 THE BURDEN OF MIGRAINE: BEYOND DIRECT HEALTH CARE COST:

Badia, X ; Magaz, S ; Gutiérrez, L
Value in Health. 5 (2002) 6 - p. 509 , 2002

Link: https://doi.org/10.1016/..